128 related articles for article (PubMed ID: 19657571)
1. SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells.
Xiao J; Yin S; Li Y; Xie S; Nie D; Ma L; Wang X; Wu Y; Feng J
Acta Biochim Biophys Sin (Shanghai); 2009 Aug; 41(8):699-708. PubMed ID: 19657571
[TBL] [Abstract][Full Text] [Related]
2. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
Huang HC; Way TD; Lin CL; Lin JK
Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer.
Uddin S; Ahmed M; Hussain AR; Jehan Z; Al-Dayel F; Munkarah A; Bavi P; Al-Kuraya KS
Lab Invest; 2009 Oct; 89(10):1115-27. PubMed ID: 19636294
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.
Katagiri Y; Hozumi Y; Kondo S
J Dermatol Sci; 2006 Jun; 42(3):215-24. PubMed ID: 16504485
[TBL] [Abstract][Full Text] [Related]
5. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
[TBL] [Abstract][Full Text] [Related]
6. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway.
Foster JS; Fernando RI; Ishida N; Nakayama KI; Wimalasena J
J Biol Chem; 2003 Oct; 278(42):41355-66. PubMed ID: 12904306
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
Su B; Chen X; Zhong C; Guo N; He J; Fan Y
J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
[TBL] [Abstract][Full Text] [Related]
10. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma.
Uddin S; Hussain A; Ahmed M; Belgaumi A; Al-Dayel F; Ajarim D; Bavi P; Al-Kuraya KS
J Pathol; 2008 Dec; 216(4):483-94. PubMed ID: 18850583
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
[TBL] [Abstract][Full Text] [Related]
12. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
[TBL] [Abstract][Full Text] [Related]
13. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
Lian C; Yang J; Wang X; Xie Y; Xiao Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
[TBL] [Abstract][Full Text] [Related]
14. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.
Koo KH; Kim H; Bae YK; Kim K; Park BK; Lee CH; Kim YN
Cell Death Dis; 2013 Jun; 4(6):e693. PubMed ID: 23807222
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
[TBL] [Abstract][Full Text] [Related]
17. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
Supriatno ; Harada K; Yoshida H; Sato M
Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells.
Lee SH; McCormick F
J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study.
Liu Z; Fu Q; Lv J; Wang F; Ding K
J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157
[TBL] [Abstract][Full Text] [Related]
20. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma.
Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T
Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]